Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Role of Ceramidases in Sphingolipid Metabolism and Human Diseases

Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY.

Cells. 2019 Dec 4;8(12):1573. doi: 10.3390/cells8121573.

Rhinorrhea as a Result of Alzheimer's Disease Treatment: A Case Report

Bartlett D, Bear M.

Sr Care Pharm. 2019 Dec 1;34(10):669-673. doi: 10.4140/TCP.n.2019.669.

Natural products and their derivatives as multifunctional ligands against Alzheimer's disease

Patil P, Thakur A, Sharma A, Flora SJS.

Drug Dev Res. 2020 Apr;81(2):165-183. doi: 10.1002/ddr.21587. Epub 2019 Aug 20.

Mammalian phospholipase D: Function, and therapeutics

McDermott MI, Wang Y, Wakelam MJO, Bankaitis VA.

Prog Lipid Res. 2020 Apr;78:101018. doi: 10.1016/j.plipres.2019.101018. Epub 2019 Dec 9.

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Coimbra JR, Sobral PJ, Santos AE, Moreira PI, Salvador JA.

Future Med Chem. 2019 Dec;11(24):3179-3194. doi: 10.4155/fmc-2019-0163.

New Therapeutic Targets for Brain Function and Disease

van Lier JE.

J Med Chem. 2020 Jun 25;63(12):6474-6476. doi: 10.1021/acs.jmedchem.9b01947. Epub 2019 Dec 17.

Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update

Villa C, Suphesiz H, Combi R, Akyuz E.

Mech Ageing Dev. 2020 Jan;185:111197. doi: 10.1016/j.mad.2019.111197. Epub 2019 Dec 17.

Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers

Gopalan D, Pandey A, Udupa N, Mutalik S.

J Control Release. 2020 Mar 10;319:183-200. doi: 10.1016/j.jconrel.2019.12.034. Epub 2019 Dec 19.

[The Convergence of Alzheimer's Disease Pathogenesis Concepts]

Kozin SA, Makarov AA.

Mol Biol (Mosk). 2019 Nov-Dec;53(6):1020-1028. doi: 10.1134/S0026898419060107.

Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease?

Dos Santos SM, Romeiro CFR, Rodrigues CA, Cerqueira ARL, Monteiro MC.

Oxid Med Cell Longev. 2019 Nov 30;2019:8409329. doi: 10.1155/2019/8409329. eCollection 2019.

Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement

Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C, Bild W, Ababei DC.

Biomolecules. 2019 Dec 26;10(1):40. doi: 10.3390/biom10010040.

Therapeutic Study of Phytochemicals Against Cancer and Alzheimer's Disease Management

Ahmad SS, Waheed T, Rozeen S, Mahmood S, Kamal MA.

Curr Drug Metab. 2019;20(13):1006-1013. doi: 10.2174/1389200221666200103092719.

Neuroprotective Effects of Quercetin in Alzheimer's Disease

Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK.

Biomolecules. 2019 Dec 30;10(1):59. doi: 10.3390/biom10010059.

Challenges in the Discovery of Novel Therapeutic Agents in Cancer

Nagaraju GP, Kamal MA.

Curr Drug Metab. 2019;20(13):1004-1005. doi: 10.2174/138920022013200123122311.

Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics

Cassidy L, Fernandez F, Johnson JB, Naiker M, Owoola AG, Broszczak DA.

Complement Ther Med. 2020 Mar;49:102294. doi: 10.1016/j.ctim.2019.102294. Epub 2019 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias